期刊文献+

以皮肤损害为首发表现的多发性骨髓瘤伴系统性淀粉样变一例 被引量:2

A case of multiple myeloma complicated by systemic amyloidosis with skin lesions as the initial manifestation
原文传递
导出
摘要 患者男,74岁,因头面部瘀斑1年入院。患者1年前无明显诱因眶周出现紫癜、瘀斑,随后前额、顶部、颞部、耳廓、口周、舌体、阴茎、肛周出现类似皮疹,摩擦、搔抓后易破溃、出血,就诊于当地医院,拟诊为“皮下出血原因待查”、“淋巴细胞浸润症?”等并予治疗(具体不详),未见明显好转,遂就诊于我院,初诊为“血管肉瘤?”
作者 伊美慧 邱莹 马金凤 李芃芃 曾倩 Yi Meihui;Qiu Ying;Ma Jinfeng;Li Pengpeng;Zeng Qian(Shandong First Medical University&Shandong Academy of Medical Sciences,Taian 271016,Shandong,China;Department of Dermatology,Jining No.1 People′s Hospital,Jining 272011,Shandong,China;Department of Hematology,Jining No.1 People′s Hospital,Jining 272011,Shandong,China;Jining Medical University,Jining 272067,Shandong,China)
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2021年第7期632-633,共2页 Chinese Journal of Dermatology
  • 相关文献

二级参考文献24

  • 1Gillmore JD, Wechalekar A, Bird J, et al. Guidelines on the diagnosis and investigation of AL amyloidosis [J]. Br J Haematol, 2015, 168(2): 207-218.
  • 2Gertz MA. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment [J]. Am J Hematol, 2014, 89(12): 1132-1140.
  • 3Comenzo RL, Reece D, Palladini G, et al. Consensus guidelines for the conduct and reporting of clinical trials in systemic light- chain amyloidosis [J]. Leukemia, 2012, 26 (11): 2317-2325.
  • 4Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J]. Leukemia, 2009, 23(2): 215-224.
  • 5Leung N, Nasr SH, Sethi S. How 1 treat amyloidosis: the impor- tance of accurate diagnosis and amyloid typing [ J]. Blood, 2012, 120( 16): 3206-3213.
  • 6Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis [J]. J Clin Oncol, 2004, 22( 18): 3751-3757.
  • 7Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements [J]. J Clin Oncol, 2012, 30(9): 989-995.
  • 8Palladini G, Dispenzieri A, Gertz MA, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes [J]. J Clin Oncol, 2012, 30(36):4541-4549.
  • 9Leung N, Glavey SV, Kumar S, et al. A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? [J]. Haematologica, 2013, 98 (6): 988-992.
  • 10Girnius S, Seldin DC, Cibeira MT, et al. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dosemelphalan and autologous stem-cell transplantation [J]. J Clin Oncol, 2013, 31 (21): 2749-2750.

共引文献49

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部